NTN Buzztime, Inc. Information Request Form

Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of NTN Buzztime, Inc. (“Buzztime” or the “Company”) (NYSE: NTN) with Brooklyn ImmunoTherapeutics LLC (“Brooklyn”). Under the terms of the merger, immediately following the closing, the members of Brooklyn collectively will own 94.08% of the outstanding common stock of the combined company and Buzztime stockholders will own 5.92% of the outstanding common stock of the combined company.

The Buzztime merger investigation concerns whether the Board of Buzztime has harmed stockholders by agreeing to enter into this transaction and whether all material facts have been properly disclosed to stockholders.